CD169+巨噬细胞通过活化CCR7/CCR8通路诱导树突细胞迁移在变应性鼻炎中的作用研究
批准号:
82071013
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
夏明
依托单位:
学科分类:
嗅觉、鼻及前颅底疾病
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
夏明
中文摘要
CD169+巨噬细胞(MФ)是一群新定义的巨噬细胞亚群,与其他细胞通过相关配体识别并结合,在抗原递呈、免疫耐受等反应中发挥重要作用。有报道称在变态反应中CD169+MФ可诱导树突细胞(DCs)迁移到次级淋巴组织,促使Th0向Th2分化,但具体机制不清。我们前期研究发现,变应性鼻炎(AR)小鼠鼻黏膜中CD169+MФ和Th2炎症相关DCs(cDC2)增多,CCR7和CCR8通路同时活化。选择性剔除CD169+MФ后,cDC2明显减少,Th2炎症改善。因此,我们推测AR小鼠鼻黏膜中CD169+MФ可能通过激活CCR7和CCR8通路,诱导cDC2迁移至黏膜固有层,促进炎症向Th2分化,导致CD4+Th细胞网络失衡。在本研究中,我们拟采用单细胞测序、流式分选等技术,明确AR小鼠鼻黏膜中CD169+MФ的表型特征,及其促进DC迁移和Th2分化的具体调控机制,揭示AR中免疫调控新机制。
英文摘要
CD169+ macrophages (MФ) is a new kind of subpopulation of macrophages, which can recognize or bind with other cells through related ligands, and plays an important role in antigen presentation, immune tolerance and other responses. It has been reported that CD169+MФ can induce dendritic cells (DCs) to migrate to secondary lymphoid tissues in allergic reactions and promote Th0 to Th2 differentiation, but the mechanism is unclear. Our previous studies found that CD169+MФ and the DCs,which are related to Th2 inflammation(cDC2),increased in the nasal mucosa of allergic rhinitis (AR) mice, and the CCR7 and CCR8 pathways were activated simultaneously. After elimination of CD169+MФ, cDC2 were significantly reduced and Th2 inflammation was improved. Therefore, we speculated that CD169+MФ in the nasal mucosa may induce the migration of cDC2 to the lamina propria by activating the CCR7 and CCR8 pathways, and promote the differentiation of Th2 inflammation through related cytokines and co-stimulatory molecules, leading to an imbalance in the CD4+Th cell network. In this study, we intend to use single cell sequencing, flow sorting, and other technologies to clarify the phenotypic characteristics of CD169+MФ in the nasal mucosa of mice and their specific regulatory mechanisms for DCs migration and Th2 differentiation, in an attempt to reveal the new mechanism of local immune regulation of nasal mucosa in AR.
过敏性鼻炎不仅影响患者的身体健康,还会引发睡眠障碍、工作学习效率降低等连锁反应。CD169+巨噬细胞是一群新型免疫细胞,可塑性极强,在多种生理活动中扮演重要角色。我们选取临床患者鼻黏膜进行免疫荧光染色发现过敏性鼻炎患者鼻黏膜中CD169巨噬细胞明显升高。之后我们利用白喉毒素转基因小鼠构建过敏性鼻炎动物模型,应用流式细胞学检测、ELISA检测、共培养体系建立等分子生物学技术,证明CD169+巨噬细胞可通过Keap1/Nrf2/HO-1 轴上调其内部丙氨酸的生成和ROS水平并释放到鼻黏膜微环境中,又通过SLC38A2促进树突状细胞对丙氨酸的摄取,调控树突状细胞的迁移和成熟,激活过敏性鼻炎的级联反应。本研究拓宽了我们对CD169+巨噬细胞作用的认识,并为AR患者提供了潜在诊疗的新靶点。
国内基金
海外基金